Peptidylprolyl isomerase (2) Mice (2) Ligands (2) Fusion (2) Cells (2) administration (1) spectacle (1) protéine (1) pharmacocinétique (1) persistance (1) famille (1) exposition (1) dose (1) survie (1) Development (1) Treatment (1) Year (1) Will (1) Week (1) Volunteers (1) Survival (1) State, The (1) Serum (1) Proteoglycans (1) Political science (1) Pharmacokinetics (1) Persistence (1) Patients (1) Motion (1) Mechanics, Analytic (1)